3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Ovarian Neoplasms
9
Fallopian Tube Neoplasms
8
Breast Neoplasms
6
Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Recurrence
3
Prostatic Neoplasms
3
Endometrial Neoplasms
3
Small Cell Lung Carcinoma
2
Metastatic Castration Resistant Prostate Cancer
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumor, Unspecified, Adult
1
Solid Tumor
1
Prostate Cancer Metastatic
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related
1
Lung Neoplasms
1
Genital Neoplasms, Male
1
Genital Neoplasms, Female
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Advanced Gastric Cancer
1
Adenocarcinoma, Clear Cell
1
Adenocarcinoma of Lung
1
Interventions
Oxaliplatin
5
Capecitabine
5
Cisplatin
4
Paclitaxel
3
Fluorouracil
3
camrelizumab
2
apatinib
2
S 1 (combination)
2
Leucovorin
2
Docetaxel
2
titanium silicide
1
rucaparib
1
relatlimab
1
pazopanib
1
linrodostat
1
ezogabine
1
endostar protein
1
dacomitinib
1
capivasertib
1
Sunitinib
1
Nivolumab
1
Metabolic Networks and Pathways
1
Irinotecan
1
Ipilimumab
1
Everolimus
1
Epirubicin
1
Electroporation
1
Drug Therapy, Combination
1
Drug Therapy
1
Congresses as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Gastric Cancer
×
rucaparib
×
Clear all
NCT02935634
2023-06-09
FRACTION-GC
Bristol-Myers Squibb
Phase 2
Completed
190 enrolled
25 charts